Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LEXX

Recent news which mentions LEXX

< Previous 1 2 3 4 Next >
Lexaria Bioscience Committed to Innovation and Improving Quality of Life
Tickers LEXX
Tags Penny Stocks Benzinga Market News
From Benzinga
Lexaria's Upcoming R&D Programs Targeting Global Markets Exceeding $160B
Tickers LEXX
Tags LEXX Benzinga Global
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tickers ADXS ENSC FWBI GALT
Tags RSLS FWBI THMO
From Benzinga
52 Biggest Movers From Yesterday
Tickers AVCT AZYO BKKT CASY
Tags Pre/Market Outlook SYTA VECT
From Benzinga
Lexaria Bioscience Featured in Virtual Coverage of Benzinga's Small Cap Conference
Tickers LEXX
Tags Biotech Small Cap InvestorBrandNetwork
From Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
Tickers AVCT CASY CNTX CORT
Tags CTK Benzinga Penny Stocks
From Benzinga
Why Lexaria Shares Are Rising Today
Tickers LEXX
Tags why it's moving Market News Movers
From Benzinga
Read Why Lexaria Bioscience Shares Are Surging During Wednesday Premarket?
Tickers LEXX
Tags Long Ideas Market News Trading Ideas
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tickers BPTH CLXT DARE ENSC
Tags CLXT LEXX Benzinga
From Benzinga
Lexaria Bioscience Embarking on Potentially Pivotal Study to Evaluate DehydraTECH-CBD
Tickers LEXX
Tags Health Care LEXX General
From Benzinga
Lexaria's DehydraTECH(TM) Demonstrates 10-20X Faster Nicotine Delivery in Recent Study
Tickers LEXX TM
Tags Benzinga Cannabis Markets
From Benzinga
Lexaria Bioscience's DehydraTECH(TM) Drug Delivery Tech Finding Multiple Applications
Tickers LEXX TM
Tags LEXX General Health Care
From Benzinga
Lexaria Bioscience Announces 2022 DehydraTECH(TM) R&D Programs
Tickers LEXX TM
Tags Benzinga Market News LEXX
From Benzinga
Lexaria Bioscience Corp. Embarks on Ambitious Hypertension Clinical Study
Tickers LEXX
Tags LEXX General Health Care
From Benzinga
Lexaria Expands 2022 R&D Programs to Evaluate Alzheimer's, Diabetes
Tickers LEXX
Tags Partner Content Market News InvestorBrandNetwork
From Benzinga
Lexaria Bioscience Corp. Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology's Efficacy in Reducing/Inhibiting Seizure Activity
Tickers IPOS LEXX TECH TM
Tags Partner Content IPOs InvestorBrandNetwork
From Benzinga
Lexaria Bioscience Corp. to Expand Hypertension Clinical Program Through Most Ambitious Study to Date
Tickers LEXX
Tags Market News Benzinga Biotech
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Tickers AGRX AVRO BCRX CMPX
Tags Market News MPLN GKOS
From Benzinga
Lexaria Bioscience Corp. Begins R&D Program Comparing DehydraTECH-CBD with Generic CBD, Epidiolex
Tickers LEXX
Tags Partner Content Regulations Government
From Benzinga
Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures
Tickers JAZZ LEXX
Tags General Movers News
From Benzinga
Lexaria Bioscience Corp.'s DehydraTECH(TM) Addresses the Needs of Medical THC Users
Tickers LEXX TM
Tags LEXX Health Care General
From Benzinga
Lexaria Starts IND-Enabling Program For DehydraTECH-CBD For Hypertension
Tickers LEXX
Tags Briefs News Biotech
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Tickers AEI ARQQ ATIF BBIG
Tags Market News KDMN CEI
From InvestorPlace
CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Results Of Human Clinical Study Showing Effective, Safe BP Reduction
Tickers CBD LEXX
Tags LEXX General Health Care
From Benzinga
Why Lexaria Bioscience Shares Are Trading Higher Today
Tickers LEXX
Tags Benzinga Market News Chris Bunka
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Tickers ADAP APOP BMRN FWP
Tags APOP Pre/Market Outlook FWP
From Benzinga
Lexaria Bioscience's Formulated Cannabidiol Lowers Blood Pressure In Hypertension Patients
Tickers LEXX
Tags LEXX Health Care Biotech
From Benzinga
Lexaria Bioscience Corp. (NASDAQ: LEXX) Targets Burgeoning Hypertension, Antiviral Therapeutics Markets With Drug Delivery Technology
Tickers LEXX TECH
Tags Logistics General Partner Content
From Benzinga
Lexaria's R&D Program Reveals 5 Exciting Results Within 2 Months
Tickers LEXX
Tags lexaria bioscience General LEXX
From Benzinga
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
Tickers ACB BLIN CAT CGC
Tags BLIN GME CHPT
From InvestorPlace
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.